Science Exchange
-78%
est. 2Y upside i
Rank
#3193
Sector
Life Sciences Software
Est. Liquidity
~2Y
Data Quality
Data: MediumScience Exchange, now a private equity-backed company, presents a moderate upside opportunity (estimated 21.75% over two years) for a job seeker.
Last updated: March 10, 2026
Under Waud Capital's ownership, Science Exchange aggressively expands its platform capabilities and market reach, potentially through strategic acquisitions, achieving significant market share in the R&D outsourcing space. Revenue could grow to $70M-$80M within two years, justifying a valuation of $500M+ at a 7-8x multiple, representing a 75% upside for common equity holders.
Science Exchange continues its steady growth trajectory, meeting Waud Capital's performance targets through organic expansion and operational efficiencies. Revenue reaches approximately $45M-$50M in two years. The company's valuation increases modestly to around $345M, reflecting a 20% upside, primarily driven by revenue growth and stable margins under private equity stewardship.
Increased competition from Scientist.com and larger enterprise software providers, coupled with slower-than-expected market adoption or integration challenges post-acquisition, hampers growth. Revenue stagnates around $30M-$35M. The valuation could decline to $170M-$200M, resulting in a -40% downside for common equity, significantly impacted by the high preference stack from prior funding rounds.
Preference Stack Risk
highInvestors hold approximately $83M in liquidation preferences, representing 28.8% of the estimated current valuation of $288M.
Dilution Risk
moderateFuture dilution may occur through management incentive plans or additional capital injections by Waud Capital, but traditional venture rounds are unlikely.
Secondary Liquidity
noneAs a private equity-backed company, active secondary markets or tender offers are unlikely within a 2-year horizon.
Last updated: February 18, 2026
Questions to Ask at the Interview
Strategic questions based on Science Exchange's data — designed to show you've done your homework.
- 1
“How does Waud Capital Partners envision Science Exchange's growth strategy and market positioning evolving over the next 3-5 years, particularly concerning direct competitors like Scientist.com and potential threats from larger enterprise software providers?”
- 2
“Given the acquisition by Waud Capital, what are the key performance indicators (KPIs) and growth milestones the company is focused on achieving in the next 12-24 months, and how will employee equity be tied to these targets?”
- 3
“With the company now under private equity ownership, what are the anticipated timelines and potential mechanisms for a future liquidity event for employees holding equity, and how does the current preference stack impact these expectations?”
Community
Valuation Sentiment
Our model estimates -78% upside. What do you think?
Anonymous. Do not share material non-public information.
Community Discussion
Comments are reviewed before they appear publicly.
Loading comments...
Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.